ISSN: 1177-1062

Journal Home

Journal Guideline

Molecular Diagnosis and Therapy Q1 Unclaimed

Adis International Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Molecular Diagnosis and Therapy is a journal indexed in SJR in Medicine (miscellaneous) and Genetics with an H index of 68. It has a price of 2990 €. It has an SJR impact factor of 1,214 and it has a best quartile of Q1. It has an SJR impact factor of 1,214.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Genetics (Q1) Medicine (miscellaneous) (Q1) Pharmacology (Q1) Molecular Medicine (Q2)

Price

2990 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,214

SJR Impact factor

68

H Index

55

Total Docs (Last Year)

174

Total Docs (3 years)

4152

Total Refs

719

Total Cites (3 years)

171

Citable Docs (3 years)

4.28

Cites/Doc (2 years)

75.49

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1

Compare this journals

Aims and Scope

Best articles by citations

The Diagnostic and Prognostic Potential of microRNAs in Epithelial Ovarian Carcinoma

A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention

Immunoscore¬Æ: A Diagnostic Assay for Clinical Management of Colon Cancer

Distribution of EGFR Mutations in 10,607 Russian Patients with Lung Cancer

Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases

Cardiac Troponins I and T: Molecular Markers for Early Diagnosis, Prognosis, and Accurate Triaging of Patients with Acute Myocardial Infarction

Colorimetric Polymer Assay for the Diagnosis of Plasma Lipids Atherogenic Quality in Hypercholesterolemic Patients

Impact of Availability of Companion Diagnostics on the Clinical Development of Anticancer Drugs

New Strategies for Blood Donor Screening for Hepatitis B Virus

Mining Cancer Transcriptomes: Bioinformatic Tools and the Remaining Challenges

Elecsys¬Æ AMH Assay: A Review in Anti-Mullerian Hormone Quantification and Assessment of Ovarian Reserve

MicroRNAs, a Promising Target for Breast Cancer Stem Cells

SHOW MORE ARTICLES

Effect of Cysteamine on Mutant ASL Proteins with Cysteine for Arginine Substitutions

Molecular Testing in EBUS-TBNA Specimens of Lung Adenocarcinoma: A Study of Concordance Between Cell Block Method and Liquid-Based Cytology in Appraising Sample Cellularity and EGFR Mutations

Integrated Interaction Network of MicroRNA Target Genes in Keloid Scarring

SNAP-Tag Technology: A Promising Tool for Ex Vivo Immunophenotyping

Innovative Therapies for Cystic Fibrosis: The Road from Treatment to Cure

Authors' Reply to Crampe and Langabeer: Technical Issues Behind Molecular Monitoring in Chronic Myeloid Leukemia

CA-SSR1 Polymorphism in Intron 1 of the EGFR Gene in Patients with Malignant Tumors Who Develop Acneiform Rash Associated with the Use of Cetuximab

Analysis of rs8067378 Polymorphism in the Risk of Uterine Cervical Cancer from a Polish Population and its Impact on Gasdermin B Expression

Comment on: Technical Issues Behind Molecular Monitoring in Chronic Myeloid Leukemia

Genetic Polymorphisms of Surfactant Protein D rs2243639, Interleukin (IL)-1beta rs16944 and IL-1RN rs2234663 in Chronic Obstructive Pulmonary Disease, Healthy Smokers, and Non-Smokers

Performance of NucliSens HIV-1 EasyQ Version 2.0 Compared with Six Commercially Available Quantitative Nucleic Acid Assays for Detection of HIV-1 in China

The Null Polymorphism of the GSTM1/T1 Gene Is Not Associated with Susceptibility to Systemic Lupus Erythematosus: A Meta-Analysis